AstraZeneca strikes $40 million AI drug discovery deal with Insitro
The multi-year partnership will target severe liver and heart conditions, with insitro eligible for up to $1.46 billion in development and commercial milestone payments
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors endpoints.news
- AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro seekingalpha.com
- AstraZeneca strikes $40 million AI drug discovery deal with insitro channelnewsasia.com
